British Journal of Medical & Surgical Urology
Volume 2, Issue 6 , Pages 233-237 , November 2009

The role of tumor volume on outcome in prostate cancer after prostatectomy

Received 22 May 2009 ,Revised 4 August 2009 ,Accepted 23 August 2009.

References 

  1. Ravery V, Chastang C, Toublanc M, et al. Percentage of cancer on biopsy cores accurately predicts extracapsular extension and biochemical relapse after radical prostatectomy for T1–T2 prostate cancer. Eur Uorl. 2000;37:449–455
  2. Badalament RA, Miller MC, Peller PA, et al. An algorithm for predicting non-organ confined prostate cancer using the results obtained from sextant core biopsies with prostate specific antigen level. J Urol. 1996;156:1375–1380
  3. Johnstone PAS, Rossi PJ, Jani AB, Master V. ‘Insignificant’ prostate cancer on biopsy: pathologic results from subsequent radical prostatectomy. Prostate Cancer Prostatic Dis. 2007;10:237–241
  4. Manoharan M, Civantos F, Kim SS, et al. Visual estimate of percent carcinoma predicts recurrence after radical prostatectomy. J Urol. 2003;170:1194–1198
  5. Chun FKH, Briganti A, Jeldres C, et al. Tumour volume and high grade tumour volume are the best predictors of pathologic stage and biochemical recurrence after radical prostatectomy. Eur J Cancer. 2007;43:536–543
  6. Kikuchi E, Scardino PT, Wheeler TM, et al. Is tumor volume an independent prognostic factor in clinically localized prostate cancer?. J Urol. 2004;172:508–511
  7. Stamey TA, McNeal JE, Yemoto CM, et al. Biological determinants of cancer progression in men with prostate cancer. JAMA. 1999;281:1395–1400
  8. Nelson BA, Shappell SB, Chang SS, et al. Tumour volume is an independent predictor of prostate-specific antigen recurrence in patients undergoing radical prostatectomy for clinically localized prostate cancer. Urol Oncol. 2006;97:1169–1172
  9. Salomon L, Levrel O, Anastasiadis AG, et al. Prognostic significance of tumor volume after radical prostatectomy: a multivariate analysis of pathological prognostic factors. Eur Urol. 2003;43:39–44
  10. Cheng L, Koch MO, Juliar BE, et al. The combined percentage of Gleason patterns 4 and 5 is the best predictor of cancer progression after radical prostatectomy. J Clin Oncol. 2005;23:2911–2917
  11. May M, Siegsmund M, Hammermann F, et al. Visual estimation of the tumor volume in prostate cancer: a useful means for predicting biochemical-free survival after radical prostatectomy?. Prostate Cancer Prostatic Dis. 2007;10:66–71
  12. Epstein JI, Carmichael M, Partin AW, Walsh PC. Is tumor volume an independent predictor of progression following radical prostatectomy? A multivariate analysis of 185 clinical stage B adenocarcinomas of the prostate with 5 years of followup. J Urol. 1993;149:1478–1481
  13. Guzzo TJ, Vira MA, Neway W, et al. Minimal tumor volume may provide additional prognostic information in good performance patients after radical prostatectomy. Urology. 2007;69:1147–1151
  14. Carvalhal GF, Humphrey PA, Thorson P, et al. Visual estimate of the percentage of carcinoma is an independent predictor of prostate carcinoma recurrence after radical prostatectomy. Cancer. 2000;89:1308–1341
  15. Jones TD, Koch MO, Lin H, Cheng L. Visual estimation of tumour extent is not an independent predictor of prostate specific antigen recurrence. BJU Int. 2005;96:1253–1257
  16. Merrill MM, Lane BR, Reuther AM, et al. Tumor volume does not predict for biochemical recurrence after radical prostatectomy in patients with surgical Gleason score 6 or less prostate cancer. Urology. 2007;70:294–298
  17. Rampersaund EN, Sun L, Moul JW, et al. Percent tumor involvement and risk of biochemical progression after radical prostatectomy. J Urol. 2008;180:571–576
  18. Humphrey PA, Vollmer RT. Intraglandular tumor extent and prognosis in prostatic carcinoma: application of a grid method to prostatectomy specimens. Hum Pathol. 1990;21:799–804
  19. Stamey TA, Freiha FA, McNeal JE, et al. Localized prostate cancer: relationship of tumor volume to clinical significance for treatment of prostate cancer. Cancer Suppl. 1993;71:933–938
  20. Yamamoto S, Kawakami S, Yonese J, et al. Prognostic significance of cancer volume involving seminal vesicles in patients with pT3bpN0 prostate cancer. Urology. 2008;72:1224–1228
  21. Arai Y, Okubo K, Terada N, et al. Volume-weighted mean nuclear volume predicts tumor biology of clinically organ-confined prostate cancer. Prostate. 2001;46:134–141
  22. Olumi A, Richie JP, Schultz DJ, D’Amico A. Calculated volume of prostate cancer identifies patients with clinical stage T1c disease at high risk of biochemical recurrence after radical prostatectomy: a preliminary study. Urology. 2000;56:273–277
  23. Wise AM, Stamey TA, McNeal JE, Clayton JL. Morphologic and clinical significance of multifocal prostate cancers in radical prostatectomy specimens. Urology. 2002;60:264–269
  24. Cheng WS, Frydenberg M, Bergstralh EJ, et al. Radical prostatectomy for pathologic stage C prostate cancer: influence of pathologic variable and edjuvant treatment on disease outcome. Urology. 1993;42:283–291
  25. Ramos CG, Roehl KA, Antenor JAV, et al. Percent carcinoma in prostatectomy specimen is associated with risk of recurrence after radical prostatectomy in patients with pathologically organ confined prostate cancer. J Urol. 2004;172:137–140
  26. Renshaw AA, Chang H, D’Amico AV. Estimation of tumor volume in radical prostatectomy specimens in routine clinical practice. Am J Clin Pathol. 1997;107:704–708
  27. Humphrey PA, Vollmer RT. Percentage carcinoma as a measure of prostatic tumor size in radical prostatectomy tissues. Mod Pathol. 1997;10:326–333
  28. Spalding AC, Daignault S, Sandler HM, et al. Percent positive biopsy cores as a prognostic factor for prostate cancer treated with external beam radiation. Urology. 2007;69:936–940
  29. Nurani R, Wallner K, Merrick G, et al. Optimized prostate brachytherapy minimizes the prognostic impact of percent of biopsy cores involved with adenocarcinoma. J Urol. 2007;178:1968–1973
  30. Papagikos MA, Rossi PJ, Urbanic JJ, et al. A simple model predicts freedom from biochemical recurrence after low-dose rate prostate brachytherapy alone. Am J Clin Oncol. 2007;30:199–204
  31. Uhlman MA, Sun L, Stackhouse DA, et al. Tumor volume, tumor percentage involvement or prostate volume: which is predictive of PSA recurrence?. J Urol. 2009;181(Suppl.):272;(#760)
  32. Mufarrij PW, Sankin A, Godoy G, Lepor H. Pathological outcomes of candidates for active surveillance following radical prostatectomy. J Urol. 2009;181(Suppl.):607–608(#1685)

PII: S1875-9742(09)00125-6

doi: 10.1016/j.bjmsu.2009.08.002

British Journal of Medical & Surgical Urology
Volume 2, Issue 6 , Pages 233-237 , November 2009

Article Tools